Economic Impact of Alternative Adjuvant Chemotherapy Regimens for Stage III Colon Cancer

Publisher： Karger

E-ISSN： 2296-5262|32|11|647-652

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.11, 2009-10, pp. : 647-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting

By  

Oncology, Vol. 72, Iss. 3-4, 2008-01 ,pp. : 248-254

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

By  

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 426-430

Karger

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

By  

Oncology, Vol. 84, Iss. 4, 2013-02 ,pp. : 240-245

Karger

Access to resources Recommend Favorite

Usefulness of the Preoperative Administration of Tegafur Suppositories as Alternative Adjuvant Chemotherapy for Patients with Resectable Stage II or III Colorectal Cancer: A KODK4 Multicenter Randomized Control Trial

By  

Oncology, Vol. 83, Iss. 1, 2012-06 ,pp. : 16-23

Karger

Access to resources Recommend Favorite